Cookies Preferences
Close Cookie Preference Manager
Cookie Settings
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
Strictly Necessary (Always Active)
Cookies required to enable basic website functionality.
Made by Flinch 77
Oops! Something went wrong while submitting the form.

Discovering Unseen Opportunities
to Improve Healthcare

lives impacted by Rho

Building Breakthrough AI-Driven SaMD Products

New Moments of Care

Intelligent screening designed to identify and improve care for individuals at risk.

User-Centric Design

AI software that seamlessly integrates into existing clinical practice & workflows.

Value-based Model of Care

Improve healthcare quality & increase revenue through intelligent screening.


AI-driven opportunistic screening to improve population bone health.
Rho utilizes routinely captured x-rays to opportunistically identify patients at risk of osteoporosis.
Licensed by Health Canada
FDA De Novo Marketing Authorization
This product is protected by U.S. Patent No. US11737704B2. All rights reserved.

Osteoporosis Care Reimagined

Impacting care through AI-driven opportunistic screening.
1 in 4
eligible women are currently screened for osteoporosis.
of men are never screened for osteoporosis.
RhoTM can utilize
of x-rays captured during routine care.
Number of individuals with low BMD:
42 million
potential lives impacted.


AI-Driven smart atlas for bone age estimation.
Bone age assessments are one of the most cumbersome imaging procedures performed in children. Physis is an award-winning software that revolutionizes bone age assessment.

Award-winning AI Research Tool Used Globally

AI-assisted bone age estimation
16 Bit
1st Place
winner RSNA AI Challenge 2017 for
Pediatric Bone Age
Shown to have
months mean absolute error
Validated by
independent peer-reviewed publications
bone age studies analyzed
Clinical & Strategic

Current Partners